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This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based 
on 3 hours of desk-based research each day. The summary is not intended to be a comprehensive 
summary of available evidence on COVID-19 but aims to make original documents easily 
accessible to decision makers which, if relevant to them, they should go to before making 
decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
03.07.2020 HIV and risk 
of COVID-19 
death: a 
population 
cohort study 
from the 
Western 
Cape 
Province, 
South Africa 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 The effect of HIV co-
infection on C19 in 
SSA is unknown 
 This population cohort 
study found that HIV 
increased risk of C19 
mortality (associated 
with a doubling of 
C19 mortality risk), 
with similar risks 
across strata of viral 
load and 
immunosuppression 
 Current and previous 
TB also increased 
C19 mortality risk 
 Authors caution that 
whilst findings may 
over-estimate the 
HIV-associated risk 
C19 death due to 
residual confounding, 
it remains that those 
with HIV should be 
considered a high-risk 
HIV, TB, 
mortality 
2 
group for C19 
management 
03.07.2020 Prevalence 
and 
experience 
of fatigue in 
survivors of 
critical 
illness: A 
mixed-
methods 
systematic 
review 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 This mixed methods 
review shows that 
fatigue is highly 
prevalent in ICU 
survivors impacting 
on recovery 
 There is currently no 
ICU specific fatigue 
assessment tool or 
targeted intervention 
to manage this 
symptom 
 This review has 
identified factors 
which may increase 
or mitigate against 
fatigue, along with 
potential 
management 
strategies for 
consideration in future 
research and practice 
fatigue 
02.07.2020 Neurological 
associations 
of COVID-19 
The Lancet 
Neurology | 
Rapid Review 
 Careful clinical, 
diagnostic, and 
epidemiological 
studies are needed to 
help define the 
manifestations and 
burden of 
neurological disease 
caused by SARS-
coV-2 
 The proportion of 
infections leading to 
neurological disease 
will probably remain 
small, however, with 
so many people 
infected the overall 
number of 
neurological patients, 
and their associated 
health burden and 
social and economic 
costs might be large 
 These patients might 
be left with severe 
neurological sequelae 
 Healthcare planners 
and policy makers 
must prepare for this 
neurology 
3 
02.07.2020 Ethnic and 
regional 
variations in 
hospital 
mortality 
from COVID-
19 in Brazil: 
a cross-
sectional 
observational 
study 
The Lancet 
Global Health 
| Article 
 This cross-sectional 
observational study 
aimed to characterise 
the C19 pandemic in 
Brazil and assess 
variations in mortality 
according to region, 
ethnicity, 
comorbidities and 
symptoms 
 Finding: increased 
mortality in the north 
region (regional 
effect) – may be 
driven by increasing 
comorbidity burden in 
regions with lower 
levels of 
socioeconomic 
development 
 Finding: increased 
mortality in the Pardo 
and Black populations 
(ethnicity effect) – 
may be related to 
differences in 
susceptibility to 
COVID-19 and 
access to health care 
Regional, 
ethnicity, 
socioeconomic 
01.07.2020 Neurologic 
and 
radiographic 
findings 
associated 
with COVID-
19 infection 
in children 
JAMA | Brief 
Report 
 Case series of 4 
previously healthy 
children with 
neurological 
symptoms caused by 
inflammatory 
syndrome associated 
with COVID-19.  
 Two recovered, the 
other two improving 
but still in hospital and 
currently wheelchair 
bound due to muscle 
weakness.  
 Children with C19 
may present with new 
neurological 
symptoms in the 
absence of 
respiratory symptoms 
Neurology, 
children 
30.06.2020 Management 
of Mothers 
and 
Neonates in 
The Journal 
of Maternal-
Fetal & 
 This perspective aims 
to provide practical 
support for the 
planning of delivery, 
resuscitating, 
Mothers, 
neonates 
4 
Low 
Resources 
Setting 
During covid-
19 Pandemia 
Neonatal 
Medicine 
stabilizing, and 
providing postnatal 
care to an infant born 
to a mother with 
suspected or 
confirmed COVID-19 
in low-resource 
settings where 
resources for 
managing emergency 
situations are limited. 
29.06.2020 Childhood 
Multisystem 
Inflammatory 
Syndrome — 
A New 
Challenge in 
the 
Pandemic 
The New 
England 
Journal of 
Medicine | 
Editorial 
 As the Covid-19 
pandemic has 
evolved, case reports 
have appeared 
describing children 
with unusual febrile 
illnesses that have 
features of 
Kawasaki’s disease, 
toxic shock 
syndrome, acute 
abdominal conditions, 
and encephalopathy, 
along with other 
reports of children 
with fever, elevated 
inflammatory 
markers, and 
multisystem 
involvement. It is now 
apparent that these 
reports were 
describing different 
clinical presentations 
of a new childhood 
inflammatory 
disorder. 
 Two reports now 
appearing in the 
Journal describe the 
epidemiology and 
clinical features of the 
new disorder in the 
United States. 
children 
29.06.2020 Association 
of BMI and 
Obesity with 
Composite 
poor 
outcome in 
COVID-19 
adult 
medRix (not 
peer 
reviewed) | 
pre-print 
 Based on a 
systematic literature 
search from PubMed 
and Embase 
database 
 Most studies were 
conducted in China 
(55.5%) with 
remaining studies 
from French, 
obesity 
5 
patients: A 
Systematic 
Review and 
Meta-
Analysis 
Germany, and United 
States 
 Conclusion: Obesity 
is a risk factor of 
composite poor 
outcome of COVID-
19. On the other 
hand, COVID-19 
patients with 
composite poor 
outcome have higher 
BMI. BMI is an 
important routine 
procedure that should 
be assessed in the 
management of 
COVID-19 patients 
and special attention 
should be given to 
patients with obesity 
28.06.2020 Predicting 
the disease 
outcome in 
COVID-19 
positive 
patients 
through 
Machine 
Learning: a 
retrospective 
cohort study 
with Brazilian 
data 
medRix (not 
peer 
reviewed) | 
pre-print 
 Accurate diagnosis of 
patients with C19 is 
important to offer 
adequate treatment 
and prevent health 
system overload 
 This preliminary 
retrospective study 
explores predicting a 
poor prognosis in 
positive C19 patients 
and possible 
outcomes using 
machine learning 
 Machine learning 
techniques fed with 
demographic and 
clinical data including 
comorbidities can 
assist in the 
prognostic prediction 
and physician 
decision-making 
allowing a faster 
response and 
contributing to non-
overload of 
healthcare systems 
Machine 
learning 
26.06.2020 Incidence 
and severity 
of COVID-19 
in HIV-
positive 
Annals of 
Internal 
Medicine |  
 A cohort study in HIV 
clinics in 60 Spanish 
hospitals between 1 
Feb and 15 April 2020 
to describe the 
incidence and 
severity of C19 
HIV-positive, 
ART 
6 
persons 
receiving 
antiretroviral 
therapy 
among 77 590 HIV-
positive persons 
receiving ART 
 236 were diagnosed 
with C19, 151 were 
hospitalised, 15 
admitted to ICU and 
20 died 
 HIV-positive patients 
receiving TDF/FTC 
have a lower risk for 
C19 and related 
hospitalisation than 
those receiving other 
therapies 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
July 2020 COVID-19 age-
mortality curves 
are flatter in 
developing 
countries 
World Bank | 
Policy 
Research 
Working 
Paper 9313 
 Uses data on COVID-19 
deaths by age for 26 
countries 
 Data and analysis for 
estimating potential burden 
in different countries 
 On average, the age-
mortality curve is flatter in 
developing countries. In 
rich countries, people ages 
70-79 are 12.6 times as 
likely to die as those ages 
50-59. In the LMICs, this 
ratio is 3.5. 
 This pattern holds 
separately for men’s and 
women’s mortality rates 
 Authors discuss 
possibilities for differences 
across countries 
demography 
July 2020 Analyzing 
COVID-19 
pandemic for 
unequal 
distribution of 
tests, identified 
cases, deaths, 
and fatality 
Diabetes & 
Metabolic 
Syndrome: 
Clinical 
Research & 
Reviews 
 This review, identifies 
cases and deaths in 18 
most affected countries by 
COVID-19 cases and 
analyses possible factors 
for the differing fatality 
rates. 
 Countries with significant 
percentage of older 
population are vulnerable 
to a high number of deaths 
Age, testing 
7 
rates in the top 
18 countries 
due to COVID-19. 
Developed countries have 
higher per capita testing, 
whereas testing is less 
intensive in 
developing/underdeveloped 
countries. There is a 
consensus among health 
experts that COVID-19 has 
higher fatality rates for 
people above 60, however, 
with further age, this 
increases exponentially. 
Countries with higher life 
expectancy are also high-
income countries, and the 
best course of action would 
be to provide specialized 
support to self-isolate for 
people of ages 75 and 
above. 
  
29.06.2020 Statistics 
associated with 
the lethality of 
COVID-19 by 
age group and 
gender in 
Mexico 
medRix (not 
peer 
reviewed) | 
pre-print 
 Outcomes of 34,686 
SARS-CoV-2 confirmed 
cases analysed of patients 
attending the IMSS 
(Mexican Institute for 
National Insurance) from 
January 2 to June 23, 
2020. We calculated 
relative IFR by age group 
and gender and introduced 
the concept of adjusted 
lethalities, that can be used 
to project the burden of the 
disease for a population 
with different demographic 
characteristics. 
Data, age, 
gender 
29.06.2020 Predictive 
model of 
COVID-19 
incidence and 
socioeconomic 
description of 
municipalities 
in Brazil 
medRix (not 
peer 
reviewed) | 
pre-print 
 The inhabitants in cities 
with reported cases of 
COVID-19 represent more 
than 73.1% of the Brazilian 
population. 
 Stratifying the age groups 
of the inhabitants and 
accounting for the 
percentage of women and 
men does not affect 
COVID-19 incidence 
(confirmed cases/100,000 
inhabitants). The 
demographic density, the 
MHDI and the per capita 
Modelling, 
age, gender 
8 
income of the municipalities 
with cases of COVID-19 do 
not affect disease 
incidence. 
 If conditions are 
maintained, our model 
predicts 2,358,703 
(2,172,930 to 2,544,477) 
cumulative cases on July 
25, 2020. 
29.06.2020 Epidemiological 
characteristics 
of COVID-19: a 
systematic 
review and 
meta-analysis 
Epidemiology 
& Infection | 
Article 
 The incubation period and 
lag between the onset of 
symptoms and first clinical 
visit for C19 are longer than 
other respiratory viral 
infections including MERS 
and SARS 
 Quarantine periods longer 
than the mandatory 14 
days may be more justified 
for extreme cases 
Incubation 
period, 
symptom 
onset 
28.06.2020 Assessing the 
nationwide 
impact of 
COVID-19 
mitigation 
policies on the 
transmission 
rate of SARS-
CoV-2 in Brazil 
medRix (not 
peer 
reviewed) | 
pre-print 
 Analysis of the effects of 
547 published 
governmental interventions, 
and population adherence, 
on the dynamics of C19 
cases across all 27 
Brazilian states 
 Results show that 
population adherence to 
social distance 
recommendations plays an 
important role in the 
effectiveness of 
interventions 
 This is a major challenge to 
the control of C19 in LMICs 
Mitigation, 
NPI 
  
9 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
02.07.2020 Community 
vulnerability to 
epidemics in 
Nepal: A high-
resolution 
spatial 
assessment 
amidst 
COVID-19 
pandemic 
medRxiv (not 
peer-reviewed) 
| pre-print 
 Knowledge of 
community 
vulnerability to C19 
could assist efficient 
deployment of 
available limited 
resources 
 This study 
assembled 
geospatial 
indicators to create 
3 vulnerability 
indices to aid 
different tiers of the 
existing government 
in federal system of 
Nepal to prioritise 
and improve 
planning for disease 
intervention and 
especially so where 
C19 transmission 
could have high 
severity 
Community 
vulnerability, 
resources 
  
30.06.2020 Stability of 
SARS-CoV-2 
and Other 
Coronaviruses 
in the 
Environment 
and on 
Common 
Touch 
Surfaces and 
the Influence 
of Climatic 
Conditions: A 
Review 
Transboundary 
and emerging 
diseases 
 The findings suggest a 
possible risk of fecal-
oral, foodborne, and 
waterborne 
transmission of SARS-
CoV-2 in developing 
countries that often 
use sewage-polluted 
waters in irrigation and 
have poor water 
treatment systems. 
CoVs survive longer in 
the environment at 
lower temperatures 
and lower relative 
humidity. It has been 
suggested that large 
numbers of COVID-19 
cases are associated 
with cold and dry 
climates in temperate 
Surfaces, 
climate 
 
10 
regions of the world 
and that seasonality of 
the virus spread is 
suspected. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 01.07.2020 Diagnostic 
accuracy of 
serological 
tests for covid-
19: systematic 
review and 
metanalysis 
 BMJ | 
Research 
 Sensitivity and 
specificity, stratified by 
method of serological 
testing, are reported 
 Sensitivity was higher 
at least 3 weeks after 
symptom onset 
compared with the first 
week 
 Authors call for higher 
quality clinical studies 
assessing the diagnostic 
accuracy of serological 
tests for C19 
 Available evidence  does 
not support the continued 
use of existing POC 
serological tests 
  Accuracy, 
antibody 
tests 
28.06.2020 Prevalence of 
SARS-CoV-2 
among 
workers 
returning to 
Bihar gives a 
snapshot of 
COVID across 
India 
medRix (not 
peer 
reviewed) | 
pre-print 
 India has reported the 
fourth highest number of 
confirmed SARS-CoV-2 
cases globally, although 
this is likely an 
underestimate due to little 
community testing 
 Millions of daily laborers 
left cities for their rural 
family homes when India 
partially exited from 
lockdown on 4 May 2020 
 This study tested a near-
random sample of 
laborers returning to the 
state of Bihar to estimate 
positive testing rate for 
COVID across India for a 
6-week period 
immediately following the 
initial lifting of the India’s 
lockdown 
Prevalence, 
migration 
11 
 Positive testing rates are 
only moderately 
correlated with, and 21% 
higher than, Indian states’ 
official reports, which are 
not based on random 
sampling 
 Higher prevalence among 
returning laborers may 
also reflect great C19 
spread in crowded poor 
communities such as 
slums 
29.06.2020 Assessment of 
the use and 
quick 
preparation of 
saliva for rapid 
microbiological 
diagnosis of 
COVID-19 
bioRix (not 
peer 
reviewed) | 
pre-print 
 Shortage in swabs for 
collecting nasopharyngeal 
and oropharyngeal 
samples and a shortage 
in RNA extraction kits can 
lead to a backlog in 
sample collection and 
testing 
 This study aimed to 
assess the diagnostic 
performance of direct real 
time RT-PCR detection of 
SARS-CoV-2 in heated 
saliva samples, avoiding 
the RNA isolation step, as 
an alternative and easier-
to-collect clinical sample 
to detect SARS-CoV-2 
compared to the 
diagnostic performance of 
nasopharyngeal and 
oropharyngeal swabs 
 RT-PCR can be 
performed using saliva in 
an RNA extraction free 
protocol with good 
sensitivity and specificity 
Saliva, heat 
  
12 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
03.07.2020 Convalescent 
plasma for 
COVID-19. A 
randomized 
clinical trial 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Convalescent plasma 
could be an 
inexpensive and widely 
available treatment for 
COVID-19  
 This randomised trial 
aimed to compare 
convalescent plasma 
with standard of care 
therapy in patients 
hospitalised with C19 
in the Netherlands 
 The trial was halted 
prematurely though 
after enrolment of 86 
patients. No difference 
in mortality (p=0.95), 
hospital stay (p=0.68) 
or day-15 disease 
severity (p=0.58) was 
observed between 
plasma treated patients 
and patients on 
standard of care 
 Most C19 patients 
have high neutralising 
antibody titres when 
admitted to hospital. 
Screening for 
antibodies may help 
identify those that may 
benefit most from 
convalescent plasma 
Convalescent 
plasma 
  
13 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
01.07.2020 Beyond 
COVID-19: 
A whole of 
health look 
at impacts 
during the 
pandemic 
response 
CGD | Policy 
Paper 
 Substantial evidence has 
emerged relating to the 
potential magnitude of the 
indirect health effects of the 
C19 pandemic 
 This paper provides an 
overview of the lessons 
learned from previous 
outbreaks and economic 
crises in relation to indirect 
health effects 
 Also proposes a framework 
for adopting a whole of 
health approach to the C19 
response around 4 distinct by 
interrelated sets of impacts: 
economic, environmental, 
health systems, and 
social/behavioural 
 Authors apply this framework 
to discuss what is already 
known on the indirect health 
impacts of C19 
Holistic 
approach, 
previous 
lessons 
19.06.2020 Increase in 
the Risk of 
Type 2 
Diabetes 
During 
Lockdown 
for the 
COVID19 
Pandemic 
in India: A 
Cohort 
Analysis 
Diabetes and 
metabolic 
syndrome 
 Lockdown due to the 
Coronavirus disease 2019 
(COVID 19) pandemic may 
cause weight gain and 
enhance the risk of type 2 
diabetes mellitus (T2DM). 
We aimed to determine this 
risk in apparently non-
diabetic individuals. 
 There was a trend towards 
weight gain seen in 40% of 
the cohort, with 16% of the 
population experiencing a 
2.1-5 kg weight increment. 
When all the risk parameters 
were analyzed together using 
the ADA risk engine, there 
was an increase in the ADA 
diabetes risk score in 7% of 
the population, with 6.66% in 
the high-risk group. There 
was a further increase in 
weight among 3% of the 
population who were already 
obese at baseline. 
Diabetes 
14 
29.06.2020 Impact of 
COVID-19 
Pandemic 
on 
Paediatric 
Services at 
a Referral 
Centre in 
Pakistan: 
Lessons 
From a 
Low-
Income 
and 
Middle-
Income 
Country 
Setting 
Archives of 
Disease in 
Childhood 
 Recommendations: 
paediatric healthcare 
providers must ensure that a 
safe clinic and hospital 
environment is created for 
children with both COVID-19 
and non-COVID-19 related 
illnesses so that essential 
preventive care and health 
maintenance can be 
provided to children during 
this time.  
 It is essential to continue to 
spread public health 
awareness messages about 
how to prevent COVID-19 
infection and about the 
importance of routine 
immunisations and seeking 
appropriate advice from 
healthcare providers when 
necessary.  
 If parents are reassured that 
healthcare providers will 
follow standard operating 
procedures and will wear and 
provide appropriate PPEs, 
they may be more likely to 
seek appropriate and timely 
care for their children. 
Children, 
Pakistan 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 24.06.2020 How 
villagers in 
central 
Sierra 
Leone 
understand 
infection 
risks under 
threat of 
COVID-19 
 PLOS | ONE 
 Fieldwork in two villages 
in central Sierra Leone 
suggest that rural 
people in SL retain the 
lessons of experience 
from the Ebola outbreak 
of 2014-15 
 Authors expect that rural 
populations will be able 
to apply these lessons 
to the C19 context 
reducing the need for 
draconian enforcement  
Understanding, 
outbreak 
experience 
15 
29.06.20 Digital 
tools 
against 
COVID-19: 
taxonomy, 
ethical 
challenges, 
and 
navigation 
aid 
Lancet digital 
health | 
Health policy 
 A typology of the 
primary digital public 
health applications that 
are in use are 
presented. These 
include proximity and 
contact tracing, 
symptom monitoring, 
quarantine control, and 
flow modelling. For 
each, we discuss 
context-specific risks, 
cross-sectional issues, 
and ethical concerns. 
 Recognising the need 
for practical guidance, 
we propose a navigation 
aid for policy makers 
and other decision 
makers for the ethical 
development and use of 
digital public health 
tools.  
Ethics, digital 
tools 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 26.06.2020 Framework for 
managing the 
COVID-19 
infodemic: 
methods and 
results of an 
online, 
crowdsourced 
WHO 
technical 
consultation 
 Journal of 
Medical 
Internet 
Research | 
Article 
 WHO technical online 
consultation on 
responding to the C19 
infodemic  
 594 ideas were 
distilled into a set of 
50 proposed actions 
in 5 action areas in a 
framework for 
managing infodemics 
in heath emergencies 
 6 policy implications 
to consider 
Infodemic, 
framework 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
16 
  
 
  
 No new articles found today    
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
04.07.2020 Offline” It’s time to convene 
nations to end this pandemic 
The Lancet | Comment Richard Horton 
03.07.2020 ‘I’m cautiously optimistic’: 
Imperial’s Robin Shattock on his 
coronavirus vaccine 
The Guardian | News Sarah Boseley 
02.07.2020 Will covid-19 be the catalyst for 
a “new deal” for the health and 
wellbeing of women, children 
and adolescents? 
BMJ | Blog Helen Clark 
02.07.2020 After COVID-19, a future for the 
world’s children? 
The Lancet | Comment The WHO-UNICEF-
Lancet 
Commissioners 
02.07.2020 EU guidance impedes 
humanitarian action to prevent 
COVID-19 in Syria 
The Lancet Global 
Health | Comment 
Hamid Yahiya 
Hussain 
Kasturi Sen 
02.07.2020 COVID-19 in the Caribbean 
small island developing states: 
lessons learnt from extreme 
weather events 
The Lancet Global 
Health | Comment 
Ian R Hambleton 
Selvi M Jeyaseelan 
Madhuvanti M 
Murphy 
02.07.2020 Beyond lockdown – sustainable 
COVID control for low-income 
countries 
CGD | Blog Peter Baker 
Jeremy Konyndyk 
Patrick Saez 
Kalipso Chalkidou 
17 
02.07.2020 Out of tragedy comes 
opportunity: how can global 
health multilateralism seize the 
moment? 
CGD | Blog Julia Kaufmann 
Alexander Winch  
Shu-Shu Tekle-
Haimanot 
Kalipso Chalkidou 
01.07.2020 The need for COVID-19 
research in low- and middle-
income countries 
Global Health 
Research and Policy | 
Commentary 
Madhu Gupta et al.  
01.07.2020 A framework for identifying the 
sources of indirect health effects 
of COVID-19 
CGD | Blog Y-Ling Chi 
Lydia Regan 
Cassandra Nemzoff 
Carleigh Krubiner 
Yasmine Anwar 
Damian Walker 
30.06.2020 WHO & Partners enhance 
support to COVID-19 response 
in Rohingya camps in Cox’s 
Bazar 
WHO | News   
30.06.2020 Emerging COVID-19 success 
story: Vietnam’s commitment to 
containment 
Our World In Data | 
Guest post 
Todd Pollack et al. 
29.06.2020 Healthcare technologies and 
COVID-19: speed is not always 
a good thing 
CGD | Blog Kalipso Chalkidou 
et al.  
29.06.2020 “As One World we will be 
stronger” – We need words of 
hope, not war language 
ARISE | Blog Alfred Itunga 
Beate Ringwald 
26.06.2020 WHO, partners unveil ambitious 
plan to deliver 2 billion doses of 
Covid-19 vaccine to high-risk 
populations 
STAT |News Helen Branswell 
18 
July 2020 Tackling antimicrobial resistance 
in the COVID-19 pandemic 
Bull WHO | Editorial   
02.07.2020 UN enlists 10,000 digital 
volunteers to fight COVID-19 
misinformation 
Devex | News   
01.07.2020 Accelerating development of 
SARS-CoV-2 vaccines – the role 
for controlled human infection 
models 
NEJM | Perspective Megan E. Deming 
Nelson L. Michael 
Merlin Robb et al.  
01.07.2020 Do-It-Yourself pandemic: it’s 
time for accountability in models 
Issues in Science and 
Technology | Blog 
Guru Madhavan 
30.06.2020 All bets are off for measuring 
pandemic preparedness 
Think Global Health | 
Blog 
Sawyer Crosby 
Joseph L Dieleman 
Samantha Kiernan 
Thomas J. Bollyky 
29.06.2020 No clinical benefit from use of 
lopinavir-ritonavir in hospitalised 
COVID-19 patients studied in 
RECOVERY 
RECOVERY Trial | 
News 
  
29.06.2020 Timeline of WHO’s response to 
COVID-19 
WHO | News   
28.06.2020 The hard nut of cracking who is 
vulnerable in our communities in 
the context of COVID-19 
Arise |Blog Joseph Kimani 
26.06.2020 COVID-19 research in brief: 
December, 2019 to June, 2020 
Nature | News   
25.06.2020 Ensuring continuity of 
tuberculosis care during the 
covid-19 crisis 
BMJ | Opinion Nathaly Aguilera 
Vasquez 
Tripti Pande 
19 
Petra Heitkamp 
Madhukar Pai 
24-
25.06.2020 
COVID-19 vaccine development 
and access virtual conference 
Africa CDC | News   
29.06.2020 Covid-19: Oxford Team Begins 
Vaccine Trials in Brazil and 
South Africa to Determine 
Efficacy 
BMJ | News Elisabeth Mahase 
30.06.2020 The line is forming for a COVID-
19 vaccine. Who should be at 
the front? 
Science | News Jon Cohen 
29.06.2020 Global Disparity and Solidarity in 
a Pandemic 
The Hastings Centre 
Report |Brief reflections 
Anita Ho,  Iulia 
Dascalu 
29.06.2020 What Could “Fair Allocation” 
during the Covid‐19 Crisis 
Possibly Mean in Sub‐Saharan 
Africa? 
The Hastings Centre 
Report | Essay 
Keymanthri 
Moodley, Laurent 
Ravez,  Adetayo 
Emmanuel 
Obasa  et al 
29.06.2020 Why N95 Should Be the 
Standard for All COVID-19 
Inpatient Care 
Annals of internal 
medicine | Ideas and 
opinions 
Nhu Quyen Dau, 
29.06.2020 Impact of COVID-19 lockdown 
on routine immunisation in 
Karachi, Pakistan 
Lancet Global Health | 
Correspondance 
Subhash Chandir, 
Danya Arif Siddiqi, 
Hamidreza 
Setayesh, 
Aamir Javed Khan 
29.06.2020 Applications of digital technology 
in COVID-19 pandemic planning 
and response 
Lancet digital health | 
Viewpoint 
Sera 
Whitelaw,  Prof 
Mamas A Mamas, 
Prof Eric Topol,  
Harriette G C Van 
Spall 
20 
29.06.2020 Child poverty, food insecurity, 
and respiratory health during the 
COVID-19 pandemic 
Lancet respiratory 
medicine | spotlight 
Ian P Sinha, Alice R 
Lee et al 
  
26.06.2020 ‘The epidemic is growing very 
rapidly’: Indian government 
adviser fears coronavirus crisis 
will worsen 
Nature | News Jayaprakash Muliyil 
29.06.2020 Including Immigrants is good 
policy not just during the 
pandemic, but afterwards too  
CDG | Blog Thomas Ginn 
Janeen Madan 
Keller 
29.06.2020 Worst virus fears are realized in 
poor or war-torn countries 
AP | News Gerald Imray  
Joseph Krauss 
29.06.2020 Trial of Oxford COVID-19 
vaccine starts in Brazil 
University of Oxford 
Medical Sciences 
Division | News 
  
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
2020 Social Science 
Research for 
Vaccine Deployment 
in Epidemic 
Outbreaks 
SSHAP | 
Tool 
 There is a need to understand 
different perspectives on vaccines 
and outbreaks to identify community 
perceptions surrounding vaccine 
use 
 This SSHAP Practical Approaches 
brief can be used by healthcare 
providers/NGOs, national and 
global-level policymakers, and 
industry actors to gain social 
science inputs in vaccine 
deployment efforts to provide 
practical solutions to re-occurring 
challenges, including vaccine 
refusal 
21 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
22 
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
23 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
24 
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
  
25 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
07.07.2020 
1300-1430 
BST 
Fifth Annual Health 
Financing Forum 
(AHFF): Health 
Financing Resilience 
and Sustainability 
Online event 1h 30 JLN, WB, USAID, 
GFF, GFF, CGD 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
26 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
27 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
